Metastatic Cervical Cancer Terminated Phase 1 Trials for Durvalumab (DB11714)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03277482Durvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerTreatment